(Q40931463)

25 September 2017

1 reference

title

Gynaecologic effects of tamoxifen (English)

1 reference

25 September 2017

1 reference

D Y Kuo

1

1 reference

25 September 2017

C D Runowicz

series ordinal

2

1 reference

25 September 2017

publication date

1 June 1995

1 reference

25 September 2017

1 reference

25 September 2017

volume

12

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

87-94

1 reference

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01676708

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01676708

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01676708

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01676708

Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation--is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01676708

Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01676708

Endometriosis developing during tamoxifen therapy

21 January 2018

1 reference

12 December 2020

Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer--preliminary report

1 reference

12 December 2020

Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal woman. A case report

1 reference

12 December 2020

Continuous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies

1 reference

12 December 2020

Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen

1 reference

12 December 2020

Tamoxifen and partial oestrogen agonism in postmenopausal women

1 reference

12 December 2020

Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast Cancer

1 reference

12 December 2020

Tamoxifen as risk factor for carcinoma of corpus uteri

1 reference

12 December 2020

Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function

1 reference

12 December 2020

Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy. Case report

1 reference

12 December 2020

Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells

1 reference

12 December 2020

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients

1 reference

12 December 2020

Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas

1 reference

12 December 2020

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

1 reference

12 December 2020

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

1 reference

12 December 2020

Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to an antiestrogen

1 reference

12 December 2020

Endometrial lesions in patients undergoing tamoxifen therapy

1 reference

12 December 2020

Fertility drugs and risk of ovarian cancer

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

12 December 2020

Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients

1 reference

12 December 2020

Tamoxifen as an anti-tumour agent: effect on oestrogen binding

1 reference

12 December 2020

Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients

1 reference

12 December 2020

Interactions of antiestrogens with human breast cancer in long-term tissue culture

1 reference

12 December 2020

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

12 December 2020

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

12 December 2020

Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients

1 reference

12 December 2020

Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features

1 reference

12 December 2020

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group

1 reference

12 December 2020

The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer

1 reference

12 December 2020

Exogenous hormones in the aetiology of cancer in women

1 reference

12 December 2020

The effect of tamoxifen on cervical squamous maturation in Papanicolaou stained cervical smears of post-menopausal women

1 reference

12 December 2020

Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens

1 reference

12 December 2020

Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer.

1 reference

12 December 2020

Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancer

1 reference

12 December 2020

Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer

1 reference

12 December 2020

Ovarian cancer and long-term tamoxifen in premenopausal women

1 reference

12 December 2020

Endometrial polyps in postmenopausal patients receiving tamoxifen

1 reference

12 December 2020

Tamoxifen and the uterus and endometrium

1 reference

12 December 2020

Steroid hormone receptors in carcinoma of the cervix: lack of response to an antiestrogen

1 reference

12 December 2020

Tamoxifen stimulates human papillomavirus type 16 gene expression and cell proliferation in a cervical cancer cell line

1 reference

12 December 2020

Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen

1 reference

12 December 2020

Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer Patients

1 reference

12 December 2020

Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh

1 reference

12 December 2020

Rapid growth of leiomyoma in patient receiving tamoxifen

1 reference

12 December 2020

Endocrine Consequences of Continuous Antiestrogen Therapy with Tamoxifen in Premenopausal Women

1 reference

12 December 2020

Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation

1 reference

12 December 2020

Ovarian torsion in a premenopausal woman treated with tamoxifen for breast cancer

1 reference

12 December 2020

Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III

1 reference

12 December 2020

Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen

1 reference

12 December 2020

Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen

1 reference

12 December 2020

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

12 December 2020

Uterine malignant mixed müllerian tumor in a patient on long-term tamoxifen therapy for breast cancer

1 reference

12 December 2020

Comparison between tamoxifen and clomiphene for induction of ovulation

1 reference

12 December 2020

Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

1 reference

12 December 2020

Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site

1 reference

12 December 2020

Oestrogen-like effect of tamoxifen on vaginal epithelium

1 reference

12 December 2020

Stimulatory effects of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line).

1 reference

12 December 2020

Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women

1 reference

12 December 2020

Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer

1 reference

12 December 2020

Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer

1 reference

12 December 2020

Tamoxifen in advanced breast cancer

1 reference

12 December 2020

Inhibition of protein kinase C by tamoxifen

1 reference

12 December 2020

Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells

1 reference

12 December 2020

Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells

1 reference

12 December 2020

I.C.I. 46,474 in breast cancer

1 reference

12 December 2020

Primary fallopian tube adenocarcinoma in situ associated with adjuvant tamoxifen therapy for breast carcinoma

1 reference

12 December 2020

Four case reports presenting new acquisitions on the association between breast and endometrial carcinoma

1 reference

12 December 2020

The effect of synthetic anti-oestrogens on the growth and biochemistry of rat mammary tumours

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01676708

1 reference

Dimensions Publication ID

25 September 2017

1020727917

0 references

1 reference